MICHIGAN’S FIRST PROTON FACILITY
FOR IMMEDIATE RELEASE: July 13, 2017
MICHIGAN’S FIRST PROTON FACILITY A Proton International Project Experienced Team Has Five More Centers Under Way Worldwide
Royal Oak, Michigan – July 13, 2017 – Proton International (PI) and Beaumont Health opened the state’s first proton therapy center today, offering the most advanced form of radiation treatment available to people with a wide range of cancers.
“Our Department, which has long been known for technical innovations in radiation oncology, today adds the latest in proton therapy to our arsenal,” says Craig Stevens, Chair of Radiation Oncology at Beaumont Hospital. “It has been a pleasure working with all the teams in this project. Proton International provided the needed proton-specific expertise to building and operations to help us get off to a great start!”
“This is a tremendous day for the people of Michigan,” said Chris Chandler, who founded Proton International in 2013 after developing, opening and overseeing the operation of some of the first proton centers in the United States and Europe. “Beaumont is joining a select group of the nation’s premier cancer treatment centers with this important option for patients.” Beaumont is one of the few but growing number of proton centers to open in the United States and the first for Michigan. The $40 million, 25,200-square-foot, two-story proton therapy building has a one-room proton treatment facility on the first floor and the Beaumont Children’s Pediatric Oncology and Hematology program on the second floor. Proton International participated in all phases of the development and opening of the Center including the selection of equipment, the one room Proteus One technology from IBA. The facility incorporates advanced technology from IBA including the S2C2 superconducting cyclotron.
Proton therapy is a precise alternative to X-ray radiation for treating some cancer tumors. It spares healthy tissue adjacent to the tumor and reduces or eliminates many of the short- and long-term treatment side effects, making it particularly important when treating children whose smaller size makes them vulnerable to damage from X-rays. Proton therapy is especially effective in treating solid tumors including cancers of the brain, central nervous system, eye, gastrointestinal tract, head and neck, liver lung, prostate, spine and some breast tumors. Ongoing research is enhancing the application of the therapy to additional sites.
It is conservatively estimated that some 250,000 cancer patients in the U.S. alone could benefit from proton therapy, which is mainly being used to treat solid cancer tumors. Proton International, www.protonintl.com, has an experienced team dedicated to bringing proton therapy to patients. The company works with hospitals and physician groups to develop one- and two-room proton therapy facilities, as well as larger facilities, on a turnkey basis.
Proton International is currently participating in the development of the following facilities:
- The University of Alabama at Birmingham, Birmingham Alabama
- Delray Medical Center, Delray Beach, Florida
- University Medical Center Groningen, The Netherlands
- University Hospital and the Radiation Clinic Halle, Halle (Saale), Germany;
- The University College of London Hospital.
The company’s business model ensures that projects are completed on time, on budget, and within the scope and needs of the Institution. Services include business planning, organizational structure, financing, building design and construction, installation and commissioning, equipment, staff training and more.